GlassScriptPhysician profile
Tiffany M Jessee
NPI 1205830692
$18,476.51
in general payments reported to CMS, 2019-2025
30 companies · $1,605 in 2025
The $1,605 reported for 2025 was more than what 79% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,232 · 2020: $3,019 · 2021: $2,704 · 2022: $553 · 2023: $3,528 · 2024: $834 · 2025: $1,605.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $2,250 · Education: $2,250 · Consulting Fee: $700 · Food and Beverage: $648 · Travel and Lodging: $120.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $2,250.00 |
| Education | $2,250.00 |
| Consulting Fee | $700.00 |
| Food and Beverage | $648.22 |
| Travel and Lodging | $119.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $7,978.70 | 2019-2025 | Da Vinci Surgical System |
| Davol INC. | $4,551.93 | 2020-2023 | |
| Gyrus Acmi, INC. | $1,815.00 | 2020 | |
| W. L. Gore & Associates, INC. | $1,631.74 | 2019 | |
| Medtronic, INC. | $700.00 | 2023 | |
| Ethicon US, LLC | $481.42 | 2019-2024 | Echelon Flex, Harmonic, Enseal |
| Endo Pharmaceuticals INC. | $261.67 | 2019-2023 | Nascobal |
| Takeda Pharmaceuticals U.S.A., INC. | $132.93 | 2020-2023 | Gattex |
| Medela LLC | $129.00 | 2019-2020 | |
| Tela Bio, INC. | $99.60 | 2020-2022 | |
| Integra Lifesciences Corporation | $94.26 | 2023 | Integra, Surgimend, Integra Dermal Regeneration Template |
| Conmed Corporation | $93.87 | 2023-2025 | Airseal, Abc Handpieces, Visiclear |
| Intra-Sana Laboratories | $91.31 | 2021-2022 | |
| Endogastric Solutions, INC | $66.67 | 2022 | |
| Standard Bariatrics, INC. | $52.46 | 2022 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Innovation Technologies INC | $35.87 | 2020 | |
| Shire North American Group INC | $27.46 | 2019 | |
| Boston Scientific Corporation | $23.58 | 2019 | |
| Lucid Diagnostics INC. | $22.81 | 2021 | |
| Novo Nordisk INC | $22.17 | 2022 | |
| Allergan, INC. | $21.87 | 2019 | |
| Solventum Corporation | $19.24 | 2025 | Prevena, V.A.C. Veraflo, Activ.A.C. |
| Smith+Nephew, INC. | $18.38 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $17.84 | 2020 | |
| Olympus America INC. | $17.04 | 2019 | |
| Kerecis Limited | $16.73 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Acell, INC. | $15.97 | 2020 | |
| Apollo Endosurgery US INC | $15.51 | 2019 | |
| Avanos Medical | $11.76 | 2021 | |
| Reshape Lifesciences INC. | $9.72 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tiffany Jessee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.